Navigation Links
Childhood blood lead levels rise and fall with exposure to airborne dust in urban areas
Date:2/25/2013

A new nine-year study of more than 367,000 children in Detroit supports the idea that a mysterious seasonal fluctuation in blood lead levels observed in urban areas throughout the United States and elsewhere in the northern hemisphere results from resuspended dust contaminated with lead.

The scientists, who report in the journal Environmental Science & Technology (ES&T), say the results have implications for government efforts to control childhood exposure to lead, which can have serious health consequences. ES&T is among the more than 40 peer-reviewed scientific journals published by the American Chemical Society, the world's largest scientific society. The full text of the study is available at http://pubs.acs.org/stoken/presspac/presspac/abs/10.1021/es303854c.

Shawn P. McElmurry and colleagues point out that average blood lead levels in the U.S. and globally have declined following the elimination of lead from gasoline, paint, water pipes and solder used to seal canned goods. In addition to McElmurry, who is with Wayne State University in Detroit, the international team included Sammy Zahran of Colorado State University; Gabriel M. Filipelli of Indiana University-Purdue University, Indianapolis; and Mark Laidlaw and Mark P. Taylor of Macquarie University in Sydney, Australia.

Much of the current lead in major urban areas is from those "legacy" contaminants. Modern human exposure takes the form of fine particles, deposited in the soil years ago, that are swept up into the air. Past research identified a seasonal trend in blood lead levels in children in multiple North American cities, including Washington, D.C., New York, Chicago and Milwaukee. Those levels increase, often by more than 10 percent, in July, August and September. Blood lead levels then decrease during winter and spring.

The scientists set o
'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1 2

Related biology news :

1. Is there a link between childhood obesity and ADHD, learning disabilities?
2. Research finds promising approaches to prevent Latino childhood obesity
3. Researchers discover mutations linked to relapse of childhood leukemia
4. Abuse during childhood linked to uterine fibroids in African-American women
5. Tumors evolve rapidly in a childhood cancer, leaving fewer obvious tumor targets
6. Childhood trauma leaves its mark on the brain
7. Bullying by childhood peers leaves a trace that can change the expression of a gene linked to mood
8. MicroRNA-218 targets medulloblastoma, most aggressive childhood brain cancer
9. Abuse during childhood linked to adult-onset asthma in African-American women
10. Predicting the age at menopause of women having suffered from childhood cancers
11. Gene sequencing project identifies abnormal gene that launches rare childhood leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/2w6zgs/facial ... "Facial Recognition Market by Solution, by Software, by ... 2020" report to their offering. ... technology become more efficient and cost effective. This ... investment from the commercial sector. The development of ...
(Date:5/28/2015)... 28, 2015 Industry analyst firm n-tech ... report titled "Markets for Self-Healing Materials: 2015-2022." According to ... and vascular systems, biomaterials, relevant shape memory materials ... $2.7 billion by 2020. The report ... of smart materials. Other recent n-tech reports have included ...
(Date:5/27/2015)... 2015   Codonics (codonics.com), a ... image documentation solutions and Omnicell  (omnicell.com), ... solutions, is pleased to announce their state ... Label System® (SLS), an award-winning FDA class ... Omnicell Anesthesia Workstation, helps prevent medication errors, ...
Breaking Biology News(10 mins):Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4% 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 3Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4
... For coffee lovers, the first cup of the morning is one ... grounds could eliminate one of the worst smells around sewer ... remove toxic gases from the air, scientists at The City College ... coffee grounds can sop up hydrogen sulfide gas, the chemical that ...
... DURHAM, N.H. Americans, knowledge of facts about the ... but this increase in knowledge has not translated into ... research from the Carsey Institute at the University of ... issues improved from 2006 to 2010, consistent with hopes ...
... Second Class? Confronting the Risks to U.S. ... Research Foruma unique interactive gathering of top policy ... agencies for health research, as well as nationally ... Two panels will each be followed by Q&A, ...
Cached Biology News:Carbonized coffee grounds remove foul smells 2Carsey Institute: Americans' knowledge of polar regions up, but not their concern 2World class to second class? Confronting the risks to US science and innovation 2
(Date:5/30/2015)... The Cholangiocarcinoma Foundation (CCF), a ... duct cancer, announced today the first grant recipients ... , The Foundation has awarded 5 grants ... to raise awareness about cholangiocarcinoma and inspire innovative, ... opens new pathways for diagnosis and drug discovery ...
(Date:5/30/2015)... , May 30, 2015 CTI BioPharma ... International,s Bioscience business (NYSE: BAX ) today announced ... trial examining pacritinib for the treatment of myelofibrosis – ... Annual Meeting of the American Society of Clinical Oncology ... Ill. Pacritinib is an investigational oral multikinase ...
(Date:5/30/2015)... RARITAN, N.J. , May 30, 2015 /PRNewswire/ ... Phase 2 MMY2002 (SIRIUS) trial show treatment with ... antibody – achieved an overall response rate (ORR) ... by an independent review committee, in heavily pre-treated ... among the pre-specified subgroups based on age, prior ...
(Date:5/30/2015)... IRVING, Texas , May 30, 2015 /PRNewswire/ ... data from a study in which researchers identified ... of metachronous paired glioma tumors, indicating changes in ... study observing 19 patients was a subset of ... confirmed molecular heterogeneity of the cancer. These data ...
Breaking Biology Technology:The Cholangiocarcinoma Foundation Awards $260,000 in Research Grants 2The Cholangiocarcinoma Foundation Awards $260,000 in Research Grants 3Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 2Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 3Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 4Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 5Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 6Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 7Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 8Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 9Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 10Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 2Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 3Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 4Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 5Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 6Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 7Caris Life Sciences Paired Tumor Data Identifies Key Driver Mutations and Confirms Tumor Heterogeneity in High-Grade Glioma Samples 2Caris Life Sciences Paired Tumor Data Identifies Key Driver Mutations and Confirms Tumor Heterogeneity in High-Grade Glioma Samples 3Caris Life Sciences Paired Tumor Data Identifies Key Driver Mutations and Confirms Tumor Heterogeneity in High-Grade Glioma Samples 4
... , CRANBURY, N.J., Aug. 12 Palatin Technologies, Inc. ... raise approximately $3.1 million in gross proceeds, before deducting placement agent ... of 9.5 million units, at a price of $0.33 per unit. ... and (ii) a warrant exercisable at any time on or after ...
... , OMAHA, Neb., Aug. 12 Transgenomic Inc. (OTC Bulletin Board: TBIO) announces ... Transgenomic Inc. Second Quarter 2009 Earnings Release, ... 2009 @ 5:00 p.m. Eastern, Where: http://www.transgenomic.com/events.asp?id=6 , ... at the, address above., ...
... , , WALTHAM, Mass., ... research and advisory firms focusing on pharmaceutical and healthcare issues, ... share in second- and third-line therapy since last year,s analysis ... attributed to the publication of the ENHANCE trial which called ...
Cached Biology Technology:Palatin Technologies, Inc. to Raise $3.1 Million in Registered Direct Offering 2Palatin Technologies, Inc. to Raise $3.1 Million in Registered Direct Offering 3Reminder: Transgenomic Inc. Announces Second Quarter 2009 Earnings Release Conference Call Webcast 2Merck/Schering-Plough's Zetia and Vytorin Have Lost Substantial Patient Share in Second- and Third-Line Therapy Since Last Year's Analysis of Dyslipidemia 2Merck/Schering-Plough's Zetia and Vytorin Have Lost Substantial Patient Share in Second- and Third-Line Therapy Since Last Year's Analysis of Dyslipidemia 3